ערך בספרים למניה: Guardant Health, Inc. (GH)

Guardant Health, Inc. (GH) is a leader in liquid biopsy, utilizing a business model based on regular patient screenings and insurance coverage to generate stable FCF. Strong teams of bioinformaticians and molecular biologists drive the company's development. This chart on the GURU.Markets platform, where the indicator stands at -1.67, reflects the price action of an asset whose profitability is constrained by high R&D expenses and intense competitive pressure.

Guardant Health, Inc. (GH) focuses on organic growth through its own R&D and FDA approval. An analysis of the BVPS value allows for an assessment of the company's real net asset value per share. This metric reflects the residual capital after deducting all liabilities, determining the business's internal margin of safety. A high level of this metric protects capital but requires efficient resource management. This asset falls into the category of high-tech investments.